Moderna (MRNA) came out with a quarterly loss of $3.33 per share versus the Zacks Consensus Estimate of a loss of $3.47. This compares to loss of $3.62 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 4.03%. A quarter ago, it was expected that this biotechnology company would post a loss of $3.59 per share when it actually produced a loss of $3.07, delivering a surprise of 14.48%. Over the last four quarters, the company has s ...